Quality of life assessments in dermatology

被引:121
作者
Finlay, AY [1 ]
机构
[1] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales
关键词
D O I
10.1016/S1085-5629(98)80026-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This review describes the many ways in which skin disease can adversely affect the quality of life (BOL) of patients with skin disease. Measurement of this impact is required for clinical and health service research, and may be valuable in clinical practice and in the evaluation of new drug therapy. Methods of measuring QOL in dermatology are described. These include general health measures, dermatology specific measures such as the Dermatology Life Quality Index (DLQI), the Dermatology Quality of Life Scales (DQOLS), the Dermatology Specific Quality of Life (DSQL), and Skindex, and disease specific measures such as the Psoriasis Disability Index (PDI), the Psoriasis Life Stress Inventory (PLSI), and the Acne Disability Index (ADI). Instruments used for measuring BOL in children (the Children's Dermatology Life Quality Index (CDLQI)) and for measuring the impact of atopic dermatitis on the families of affected children (the Dermatitis Family Impact (DFI) questionnaire) are described. Reasons are given for the use of such measures in clinical practice. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 54 条
[1]   Development and validation of a quality of life instrument for cutaneous diseases [J].
Anderson, RT ;
Rajagopalan, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (01) :41-50
[2]  
[Anonymous], BR J DERMATOL
[3]   Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness [J].
Chren, MM ;
Lasek, RJ ;
Quinn, LM ;
Mostow, EN ;
Zyzanski, SJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (05) :707-713
[4]   Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases [J].
Chren, MM ;
Lasek, RJ ;
Flocke, SA ;
Zyzanski, SJ .
ARCHIVES OF DERMATOLOGY, 1997, 133 (11) :1433-1440
[5]  
CLARK SM, 1997, BR J DERMATOL S50, V137, P41
[6]  
DETIEDRA AG, IN PRESS PHARMACOECO
[7]   The economic impact of psoriasis increases with psoriasis severity [J].
Feldman, SR ;
Fleischer, AB ;
Reboussin, DM ;
Rapp, SR ;
Bradham, DD ;
Exum, ML ;
Clark, AR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 37 (04) :564-569
[8]   VALIDATION OF SICKNESS IMPACT PROFILE AND PSORIASIS DISABILITY INDEX IN PSORIASIS [J].
FINLAY, AY ;
KHAN, GK ;
LUSCOMBE, DK ;
SALEK, MS .
BRITISH JOURNAL OF DERMATOLOGY, 1990, 123 (06) :751-756
[9]   DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].
FINLAY, AY ;
KHAN, GK .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216
[10]   The outcomes movement and new measures of psoriasis [J].
Finlay, AY .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1997, 36 (03) :502-503